Amgen Reports Fourth Quarter And Full Year 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to Amgen Reports Fourth Quarter And Full Year 2017 Financial Results

Amgen (AMGN) PT Raised to $205 at Bernstein Following 4Q

February 2, 2018 8:06 AM EST

Bernstein raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $189.00) while maintaining a Market Perform rating following the company's 4Q earnings report. Amgen missed a bit on top line with a bit more of a material miss on EPS ($5,602, -0.7%; $2.89, -14c). The... More

Amgen (AMGN) PT Raised to $224 at Oppenheimer

February 2, 2018 6:54 AM EST

Oppenheimer raised its price target on Amgen (NASDAQ: AMGN) to $224.00 (from $205.00) while maintaining an Outperform rating.

Analyst Leah Rush Cann commented, "Amgen reported GAAP earnings per share, before a one-time tax-reform charge, of $2.70, which is 9.2% lower than our estimate of $2.97. Earnings were... More

Amgen (AMGN) Misses Q4 EPS by 14c

February 1, 2018 4:02 PM EST

Amgen (NASDAQ: AMGN) reported Q4 EPS of $2.89, $0.14 worse than the analyst estimate of $3.03. Revenue for the quarter came in at $5.8 billion versus the consensus estimate of $5.83 billion.

GUIDANCE:

Amgen sees FY2018 EPS of $12.60-$13.70, versus the consensus of $12.71.

For the fourth quarter, total revenues decreased 3 percent versus the fourth quarter of 2016 to $5.8... More